Sabaa Joad, MD
Endocrinology, Diabetes & Metabolism · Park Ridge, ILNPI 1629314372
Payments from drug & device makers
Across 84 payments — averaging $27.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$301
- Xeris Pharmaceuticals, Inc.$271
- Ascensia Diabetes Care US Inc.$254
- Sanofi-aventis U.S. LLC$212
- Amgen$181
- Abbott$129
- plus $971 from 19 others
What the payments were for
- Food & beverage$2,20395%
- Education$562%
- Gifts$593%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $301 |
| Xeris Pharmaceuticals, Inc. | 10 | $271 |
| Ascensia Diabetes Care US Inc. | 5 | $254 |
| Sanofi-aventis U.S. LLC | 6 | $212 |
| Amgen | 4 | $181 |
| Abbott | 7 | $129 |
| Insulet Corporation | 5 | $123 |
| Mannkind Corporation | 3 | $121 |
| Ascendis Pharma Endocrinology Inc | 5 | $102 |
| Corcept Therapeutics | 4 | $89 |
| Novo Nordisk | 5 | $87 |
| AbbVie | 4 | $73 |
| Eton Pharmaceuticals, Inc. | 1 | $66 |
| Johnson & Johnson | 2 | $45 |
| Dexcom, Inc. | 2 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Pfizer | 1 | $31 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Rhythm Pharmaceuticals, Inc. | 1 | $26 |
| Amryt Pharma Holdings Ltd | 1 | $21 |
| Chiesi USA, Inc. | 1 | $20 |
| Amphastar Pharmaceuticals, Inc. | 1 | $18 |
| Sequel Med Tech, LLC | 1 | $17 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Tolmar, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVERSENSE 365 SENSOR KIT (RETAIL)$173
- Prolia$139
- TZIELD$130
- MOUNJARO$124
- GVOKE HYPOPEN$122
How this compares
$2,318 in reported general payments places this provider in the 65th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.
See all endocrinology, diabetes & metabolism providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 102 | $166,592 |
| MounjaroTirzepatide | 82 | $103,478 |
| JardianceEmpagliflozin | 76 | $101,413 |
| TrulicityDulaglutide | 36 | $61,927 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 66 | $11,774 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $8,066 |
| HumalogInsulin Lispro | 20 | $6,650 |
| Novolog FlexpenInsulin Aspart | 19 | $6,253 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $4,690 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 28 | $2,814 |
| Humalog Kwikpen U-100Insulin Lispro | 11 | $2,535 |
| Levothyroxine Sodium | 129 | $1,395 |
| SynthroidLevothyroxine Sodium | 14 | $811 |
| Metformin Hcl ErMetformin Hcl | 54 | $709 |
| Metformin Hcl | 60 | $531 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $301 | $172,055138 claims |
| Novo NordiskOzempic | $87 | $166,592102 claims |
| AbbVieSynthroid | $73 | $81114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.
Other endocrinology, diabetes & metabolism in Park Ridge
- Toral PatelPark Ridge$27K
- Liana BillingsSkokie$3.4M
- Leon FogelfeldChicago$1.5M
- Grazia AleppoChicago$1.4M
- Wahid KassarChicago$884K
- Anthony PickLake Forest$665K
- Hiralal MaheshwariMcHenry$642K
- Wenyu HuangChicago$639K
- Babak PazookiJoliet$582K
- Silvana PannainChicago$575K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.